ONCOMED LETTERHEADOncoMed Pharmaceuticals Inc • March 7th, 2019 • Pharmaceutical preparations
Company FiledMarch 7th, 2019 IndustryYou and OncoMed Pharmaceuticals, Inc. (the “Company”) are parties to an Amended and Restated Change in Control and Severance Agreement dated October 14, 2015 (the “Change in Control Agreement”), which sets forth, among other things, the terms and conditions of certain severance benefits payable to you in the event of a qualifying termination of your employment. This letter (this “Agreement”) amends and restates the Change in Control Agreement to provide you with additional benefits in the event of certain terminations of your employment. This Agreement supersedes the Change in Control Agreement and any other agreement or policy to which the Company is a party with respect to the cessation of your employment with the Company.
ContractOncoMed Pharmaceuticals Inc • March 10th, 2016 • Pharmaceutical preparations • California
Company FiledMarch 10th, 2016 Industry Jurisdiction[DATE] [NAME] [ADDRESS] Re: Amended and Restated Change in Control and Severance Agreement Dear [NAME]: You and OncoMed Pharmaceuticals, Inc. (the “Company”) are parties to a Change in Control and Severance Agreement dated [_____________] (the “Change in Control Agreement”), which sets forth, among other things, the terms and conditions of certain severance benefits payable to you in the event of a qualifying termination of your employment. This letter (this “Agreement”) amends and restates the Change in Control Agreement to provide you with additional benefits in the event of certain terminations of your employment. This Agreement supersedes the Change in Control Agreement and any other agreement or policy to which the Company is a party with respect to the cessation of your employment with the Company. 1. Definitions. For purposes of the Agreement, the following terms shall have their respective meanings set forth below: (a) “Cause” shall mean any of the following: (i) your intention